Yang Y, Smucny J, Zhang H, Maddock R
Neuroimage Clin. 2023; 39:103461.
PMID: 37406595
PMC: 10509531.
DOI: 10.1016/j.nicl.2023.103461.
Merritt K, McCutcheon R, Aleman A, Ashley S, Beck K, Block W
Mol Psychiatry. 2023; 28(5):2039-2048.
PMID: 36806762
PMC: 10575771.
DOI: 10.1038/s41380-023-01991-7.
Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M
Mol Psychiatry. 2021; 27(1):744-757.
PMID: 34584230
DOI: 10.1038/s41380-021-01297-6.
Merritt K, McGuire P, Egerton A, Aleman A, Block W, Bloemen O
JAMA Psychiatry. 2021; 78(6):667-681.
PMID: 33881460
PMC: 8060889.
DOI: 10.1001/jamapsychiatry.2021.0380.
Sendi M, Zendehrouh E, Ellis C, Liang Z, Fu Z, Mathalon D
Front Neural Circuits. 2021; 15:649417.
PMID: 33815070
PMC: 8013735.
DOI: 10.3389/fncir.2021.649417.
Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts.
Martens L, Herrmann L, Colic L, Li M, Richter A, Behnisch G
Sci Rep. 2021; 11(1):6742.
PMID: 33762638
PMC: 7990923.
DOI: 10.1038/s41598-021-86220-3.
Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H, Craven A, Sinceviciute I, Johnsen E, Kompus K, Bless J
Schizophr Bull. 2019; 46(3):633-642.
PMID: 31626702
PMC: 7147588.
DOI: 10.1093/schbul/sbz099.
Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Wang A, Pradhan S, Coughlin J, Trivedi A, DuBois S, Crawford J
JAMA Psychiatry. 2019; 76(3):314-323.
PMID: 30624573
PMC: 6439827.
DOI: 10.1001/jamapsychiatry.2018.3637.
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid M, Salibi N, White D, Gawne T, Denney T, Lahti A
Schizophr Bull. 2018; 45(1):180-189.
PMID: 29385594
PMC: 6293230.
DOI: 10.1093/schbul/sbx190.
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
Brandt A, Unschuld P, Pradhan S, Lim I, Churchill G, Harris A
Schizophr Res. 2016; 172(1-3):101-5.
PMID: 26925800
PMC: 4821673.
DOI: 10.1016/j.schres.2016.02.017.
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Mouchlianitis E, Bloomfield M, Law V, Beck K, Selvaraj S, Rasquinha N
Schizophr Bull. 2015; 42(3):744-52.
PMID: 26683625
PMC: 4838083.
DOI: 10.1093/schbul/sbv151.
In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.
Wijtenburg S, Yang S, Fischer B, Rowland L
Neurosci Biobehav Rev. 2015; 51:276-95.
PMID: 25614132
PMC: 4427237.
DOI: 10.1016/j.neubiorev.2015.01.007.
The neurobiology and treatment of first-episode schizophrenia.
Kahn R, Sommer I
Mol Psychiatry. 2014; 20(1):84-97.
PMID: 25048005
PMC: 4320288.
DOI: 10.1038/mp.2014.66.
Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system.
Gruber O, Chadha Santuccione A, Aach H
Front Psychiatry. 2014; 5:32.
PMID: 24765078
PMC: 3982059.
DOI: 10.3389/fpsyt.2014.00032.
Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Poels E, Kegeles L, Kantrowitz J, Javitt D, Lieberman J, Abi-Dargham A
Schizophr Res. 2014; 152(2-3):325-32.
PMID: 24418122
PMC: 3951718.
DOI: 10.1016/j.schres.2013.12.013.
Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.
Merritt K, McGuire P, Egerton A
Front Psychiatry. 2013; 4:151.
PMID: 24324444
PMC: 3840324.
DOI: 10.3389/fpsyt.2013.00151.
Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.
Stone J, Pepper F, Fam J, Furby H, Hughes E, Morgan C
Psychopharmacology (Berl). 2013; 231(10):2107-16.
PMID: 24264567
DOI: 10.1007/s00213-013-3354-8.
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.
Poels E, Kegeles L, Kantrowitz J, Slifstein M, Javitt D, Lieberman J
Mol Psychiatry. 2013; 19(1):20-9.
PMID: 24166406
DOI: 10.1038/mp.2013.136.
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y
Schizophr Bull. 2013; 40(5):1128-39.
PMID: 24023251
PMC: 4133658.
DOI: 10.1093/schbul/sbt124.
T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.
Bracken B, Rouse E, Renshaw P, Olson D
Psychiatry Res. 2013; 213(2):142-53.
PMID: 23769421
PMC: 3748739.
DOI: 10.1016/j.pscychresns.2013.03.005.